After GSK PLC (LSE:GSK, NYSE:GSK) shares fell sharply on the back of US authorities restricting doses of respiratory syncytial virus (RSV) vaccine,...
Vous n'êtes pas connecté
Moderna (MRNA) stock sinks after new data shows the efficacy of its mRNA-based RSV vaccine fell sharply in the second year and was lower than that of rival vaccines marketed by GSK and Pfizer.
After GSK PLC (LSE:GSK, NYSE:GSK) shares fell sharply on the back of US authorities restricting doses of respiratory syncytial virus (RSV) vaccine,...
If approved, the RSV vaccine will be Moderna's (MRNA) second approved product in the European Union.
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus, which is...
US Biomedical Advanced Research and Development Authority funds will be used to complete the development and testing of a mRNA-based vaccine for bird...
The success of COVID-19 mRNA vaccines has underscored the significant advantages of utilizing mRNA technology in vaccine development. In response,...
TUESDAY, July 2, 2024 -- U.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a...
As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to...
The U.S. Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), part of the...
Back in December of 2020, then United Staes President Donald Trump wastoutingthe supposed great accomplishment of his Operation Warp Speed quickly...
The Pfizer-BioNTech and Moderna COVID-19 vaccines both utilize messenger ribonucleic acid (mRNA) technology. Moderna patented mRNA processes that...